Download Publication

This field is for validation purposes and should be left unchanged.
Name(Required)
Consent(Required)

HDA 2026 Traceability Seminar: The New Challenge Is Interoperability

DSCSA compliance is no longer the finish line.

As the pharmaceutical supply chain enters an era of sustained operation, the focus is shifting from implementation to operational effectiveness, inspection readiness, exception management, and ecosystem-wide interoperability. Insights from the HDA Traceability Seminar 2026 reveal a clear message:

The greatest risks now sit at the intersections of systems, standards, data, partners, and processes.

In our HDA Traceability Seminar Readout, we synthesize key lessons on DSCSA operations, NDC-12 readiness, barcode and EDI interoperability, exception handling, third-party dependencies, and the critical need to preserve hard-earned implementation knowledge.

For manufacturers, distributors, 3PLs, health systems, pharmacies, technology providers, regulators, and standards organizations worldwide, one message stands out:

Work backward from 2036, map every dependency, and test where product identity can break before it does.

Download and read the full seminar synthesis and take away an understanding of the four actions you should be taking now: 

  1. Identify
  2. Assess
  3. Coordinate
  4. Test

Follow the Author

Ryan Kelly is Rx-360’s Senior Director of Supply Chain Security & Brand Protection. Inquire to join his Supply Chain Security and Direct-to-Consumer Pharmaceutical Programs working groups.